Refractory pityriasis rubra pilaris treated with abrocitinib
Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts the quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic thera...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2025-01-01
|
| Series: | Dermatology Reports |
| Subjects: | |
| Online Access: | https://www.pagepress.org/journals/dr/article/view/10105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841550763696848896 |
|---|---|
| author | Filip Rob |
| author_facet | Filip Rob |
| author_sort | Filip Rob |
| collection | DOAJ |
| description |
Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts the quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic therapies failed.
|
| format | Article |
| id | doaj-art-57f6315707e349558ed6b4ee8708b5cc |
| institution | Kabale University |
| issn | 2036-7392 2036-7406 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Dermatology Reports |
| spelling | doaj-art-57f6315707e349558ed6b4ee8708b5cc2025-01-10T01:41:43ZengPAGEPress PublicationsDermatology Reports2036-73922036-74062025-01-0110.4081/dr.2025.10105Refractory pityriasis rubra pilaris treated with abrocitinibFilip Rob0Department of Dermatovenerology, Second Faculty of Medicine, Charles University, Bulovka University Hospital, Prague Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts the quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic therapies failed. https://www.pagepress.org/journals/dr/article/view/10105Pityriasis rubra pilarisJanus kinase (JAK)abrocitinib |
| spellingShingle | Filip Rob Refractory pityriasis rubra pilaris treated with abrocitinib Dermatology Reports Pityriasis rubra pilaris Janus kinase (JAK) abrocitinib |
| title | Refractory pityriasis rubra pilaris treated with abrocitinib |
| title_full | Refractory pityriasis rubra pilaris treated with abrocitinib |
| title_fullStr | Refractory pityriasis rubra pilaris treated with abrocitinib |
| title_full_unstemmed | Refractory pityriasis rubra pilaris treated with abrocitinib |
| title_short | Refractory pityriasis rubra pilaris treated with abrocitinib |
| title_sort | refractory pityriasis rubra pilaris treated with abrocitinib |
| topic | Pityriasis rubra pilaris Janus kinase (JAK) abrocitinib |
| url | https://www.pagepress.org/journals/dr/article/view/10105 |
| work_keys_str_mv | AT filiprob refractorypityriasisrubrapilaristreatedwithabrocitinib |